+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico

  • ID: 2881896
  • Report
  • Region: Mexico
  • 120 Pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico

Summary

The author has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Mexico. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Mexico. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by the author's team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Mexico, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Boehringer Ingelheim, Bayer, Pfizer, GSK, and Genomma Lab) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche Diagnostics, Essilor, Zimmer Biomet and Abbott)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Mexico
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Mexico
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities and challenges to growth in the Mexican healthcare market.
Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Mexican healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Mexican healthcare market.
Note: Product cover images may vary from those shown
2 of 2
  • Executive Summary
  • Overview of Pharmaceutical Market
  • Overview of Medical Device Market
  • Deals Analysis
  • Porter’s Five Forces Model
  • Market Access
  • Country Healthcare Landscape
  • Opportunities and Challenges
  • Appendix
List of Tables
Table 1: Ophthalmic Devices Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 2: Orthopedic Devices Market, Mexico, Revenue ($m) and Market Share (%) of Major Companies, 2018
Table 3: Hospital Supplies Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2017
Table 4: In Vitro Diagnostics Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 5: General Surgery Devices Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 6: Approval Timelines, Mexico, 2019
Table 7: Medical Device Classification, Mexico, 2018
Table 8: Approval Process, Mexico, 2018
Table 9: Patent Fees, Mexico, 2019
Table 10: Trade Fairs, Mexico, 2019

List of Figures
Figure 1: Pharmaceutical Market, Mexico, Revenue ($B), 2010-2017
Figure 2: Medical Device Market, Mexico, Revenue ($B), 2015-2020
Figure 3: Country Profile, Mexico, 2018
Figure 4: Pharmaceutical Market, Mexico, Revenue ($B), 2010-2017
Figure 5: Pharmaceutical Market, Mexico, Revenue Forecast ($B), 2018-2022
Figure 6: Pharmaceutical Exports ($B), Mexico, 2010-2018
Figure 7: Top Export Partners, Mexico, 2018
Figure 8: Pharmaceutical Imports ($B), Mexico, 2010-2018
Figure 9: Top Import Partners, Mexico, 2018
Figure 10: Pharmaceutical Supply Chain, Mexico, 2019
Figure 11: Major Health Services (%), Mexico, 2016
Figure 12: Pharmaceutical Market, Major Players, 2017
Figure 13: Medical Device Market, Mexico, Revenue ($B), 2015-2020
Figure 14: Medical Device Market, Mexico, Revenue Forecast ($B), 2021-2025
Figure 15: Medical Device Market, Mexico, Revenue by Segment ($M), 2018
Figure 16: Ophthalmic Devices Market, Mexico, Revenue ($M), 2015-2022
Figure 17: Ophthalmic Devices Market, Mexico, Market Share of Major Players (%), 2015
Figure 18: Orthopedic Devices Market, Mexico, Revenue ($M), 2015-2022
Figure 19: Orthopedic Devices Market, Mexico, Market Share of Major Companies (%), 2018
Figure 20: Hospital Supplies Market, Mexico, Revenue ($M), 2015-2022
Figure 21: Hospital Supplies Market, Mexico, Market Share of Major Players (%), 2017
Figure 22: In Vitro Diagnostics Market, Mexico, Revenue ($M), 2015-2022
Figure 23: In Vitro Diagnostics Market, Mexico, Market Share of Major Players (%), 2018
Figure 24: General Surgery Devices Market, Mexico, Revenue ($M), 2015-2022
Figure 25: General Surgery Devices Market, Mexico, Market Share of Major Players (%), 2018
Figure 26: Diagnostic Market, Mexico, Revenue ($B), 2015-2020
Figure 27: Diagnostic Market, Mexico, Revenue ($B), 2021-2025
Figure 28: Medical Device Market, Mexico, Revenue ($B) of Major Companies, 2017
Figure 29: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Mexico, 2018-2019
Figure 30: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Mexico, 2018-2019
Figure 31: M&A Deals by Therapy Area, Pharmaceutical Market, Mexico, 2018-2019(by value and by number)
Figure 32: Medical Device Market Deals (by Deal Value and Deal Count, $M), Mexico, 2018
Figure 33: Medical Device Market Deals, Top Therapy Area by Deal Value and Count , Mexico, 2018
Figure 34: Medical Device Market Deals , (by Deal Value and Count), Mexico, 2018
Figure 35: Medical Device Market Deals, Mexico, Venture Financing Deals by Therapy Area, 2018
Figure 36: Organization of the Health System, Mexico, 2018
Figure 37: Reimbursement Pricing for New Drugs, Mexico, 2018
Figure 38: Out-of-Pocket Expenditure (% of total expenditure on health), Mexico, 2010-2016
Figure 39: Annual Rate of Change (%), Health and Welfare Services Price Index, Mexico, 2012-2018
Figure 40: Number of companies participating in CCNPMIS process and number of products negotiated, Mexico, 2008-2015
Figure 41: Drug Registration Types and Data Requirements, Mexico, 2018
Figure 42: Drug Approval Process, Mexico, 2018
Figure 43: Patent Approval Timeline, Mexico, 2016
Figure 44: Patent Approval Process, Mexico, 2016
Figure 45: Trademark Process, Mexico, 2017
Figure 46: Clinical Trial Regulations, Mexico, 2018
Figure 47: Advertising Regulations, Mexico, 2018
Figure 48: Hospitals (number), Mexico, 2010-2017
Figure 49: Hospitals by Type (number), Mexico, 2010-2017
Figure 50: Diagnostic Equipment (units per million population), Mexico, 2010-2017
Figure 51: Hospital Beds (per 1,000 population), Mexico, 2010-2017
Figure 52: Acute Care Hospital Beds (per 1,000 population), Mexico, 2010-2017
Figure 53: Psychiatric Care Hospital Beds (per 1,000 population), Mexico, 2010-2017
Figure 54: Life Expectancy (in years), Mexico, 2010-2017
Figure 55: Immunization Rate (%), Mexico, 2010-2017
Figure 56: PM2.5 (μg per m3), Mexico, 2010-2017
Figure 57: CO2 Emissions (metric tons per capita), Mexico, 2010-2017
Figure 58: Physicians (per 1,000 population), Mexico, 2010-2017
Figure 59: Nurses (per 1,000 population), Mexico, 2010-2017
Figure 60: Dentists, (per 1,000 population), Mexico, 2010-2017
Figure 61: Major Causes of Mortality (Number of deaths), Mexico, 2016
Figure 62: Major Causes of Male Mortality (Number of deaths), Mexico, 2016
Figure 63: Major Causes of Female Mortality (Number of deaths), Mexico, 2016
Figure 64: Disability-Adjusted Life Years by Major Disease (‘000), Mexico, 2016
Figure 65: Healthcare Expenditure as Percentage of GDP (%), Mexico, 2010-2017
Figure 66: Health Expenditure Share (% of total health spending), Mexico, 2010-2017
Figure 67: Healthcare spending as per providers (%), Mexico, 2016
Figure 68: Pharmaceutical Spending (% of total health spending), Mexico, 2011-2016
Figure 69: Opportunities & Challenges, Mexico
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll